Cheng M - Search Results

1

Extranodal extension of nodal metastases is a poor prognostic moderator in non-small cell lung cancer: a meta-analysis.

Luchini C, Veronese N, Nottegar A, Cheng M, Kaneko T, Pilati C, Tabbò F, Stubbs B, Pea A, Bagante F, Demurtas J, Fassan M, Infante M, Cheng L, Scarpa A. Luchini C, et al. Among authors: cheng m, cheng l. Virchows Arch. 2018 Jun;472(6):939-947. doi: 10.1007/s00428-018-2309-1. Epub 2018 Feb 1. Virchows Arch. 2018. PMID: 29392400 Review.

2

Clonality and TP53 mutation analysis of focal nodular hyperplasia of the liver.

Zheng S, Cummings OW, Saxena R, Zhang S, Wang M, Williamson SR, Cheng M, Lopez-Beltran A, Montironi R, Hodges KB, Cheng L. Zheng S, et al. Among authors: cheng m, cheng l. Am J Clin Pathol. 2010 Jul;134(1):65-70. doi: 10.1309/AJCPCIAH79EABQKM. Am J Clin Pathol. 2010. PMID: 20551268

3

Liquid Biopsies in the Management of Bladder Cancer: Next-Generation Biomarkers for Diagnosis, Surveillance, and Treatment-Response Prediction.

Yang Y, Miller CR, Lopez-Beltran A, Montironi R, Cheng M, Zhang S, Koch MO, Kaimakliotis HZ, Cheng L. Yang Y, et al. Among authors: cheng m, cheng l. Crit Rev Oncog. 2017;22(5-6):389-401. doi: 10.1615/CritRevOncog.2017020803. Crit Rev Oncog. 2017. PMID: 29604919 Review.

4

Inherited forms of bladder cancer: a review of Lynch syndrome and other inherited conditions.

Phelan A, Lopez-Beltran A, Montironi R, Zhang S, Raspollini MR, Cheng M, Kaimakliotis HZ, Koch MO, Cheng L. Phelan A, et al. Among authors: cheng m, cheng l. Future Oncol. 2018 Feb;14(3):277-290. doi: 10.2217/fon-2017-0346. Epub 2018 Jan 18. Future Oncol. 2018. PMID: 29345160 Free article. Review.

5

Can radiotherapy potentiate the effectiveness of immune checkpoint inhibitors in lung cancer?

Cheng M, Durm G, Hanna N, Einhorn LH, Kong FS. Cheng M, et al. Future Oncol. 2017 Dec;13(28):2503-2505. doi: 10.2217/fon-2017-0405. Epub 2017 Nov 23. Future Oncol. 2017. PMID: 29168656 No abstract available.

6

Greater reduction in mid-treatment FDG-PET volume may be associated with worse survival in non-small cell lung cancer.

Kong FS, Li L, Wang W, Campbell J, Waller JL, Piert M, Gross M, Cheng M, Owen D, Stenmark M, Huang KC, Frey KA, Ten Haken RK, Lawrence TS. Kong FS, et al. Among authors: cheng m. Radiother Oncol. 2019 Mar;132:241-249. doi: 10.1016/j.radonc.2018.10.006. Epub 2018 Oct 30. Radiother Oncol. 2019. PMID: 30389239 Free PMC article.

7

Modern Radiation Further Improves Survival in Non-Small Cell Lung Cancer: An Analysis of 288,670 Patients.

Cheng M, Jolly S, Quarshie WO, Kapadia N, Vigneau FD, Kong FS. Cheng M, et al. J Cancer. 2019 Jan 1;10(1):168-177. doi: 10.7150/jca.26600. eCollection 2019. J Cancer. 2019. PMID: 30662537 Free PMC article.

8

Genetic Variations in the Transforming Growth Factor-β1 Pathway May Improve Predictive Power for Overall Survival in Non-small Cell Lung Cancer.

Zhang H, Wang W, Pi W, Bi N, DesRosiers C, Kong F, Cheng M, Yang L, Lautenschlaeger T, Jolly S, Jin J, Kong FS. Zhang H, et al. Among authors: cheng m. Front Oncol. 2021 Jul 7;11:599719. doi: 10.3389/fonc.2021.599719. eCollection 2021. Front Oncol. 2021. PMID: 34307117 Free PMC article.

9

Shifting tides: reflecting on medical education in the time of covid-19.

Cheng M. Cheng M. BMJ. 2022 Mar 11;376:o657. doi: 10.1136/bmj.o657. BMJ. 2022. PMID: 35277431 No abstract available.

10

Predicting progression of in situ carcinoma in the era of precision genomics.

Cheng M, Hanna NH, Davidson DD, Gunderman RB. Cheng M, et al. J Thorac Dis. 2019 Jun;11(6):2222-2225. doi: 10.21037/jtd.2019.05.57. J Thorac Dis. 2019. PMID: 31372258 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,999 results

Search Page